Literature DB >> 9408820

Botulinum toxin in the treatment of tardive dystonia.

A Chatterjee, M Forrest Gordon, N Giladi, R Trosch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9408820     DOI： 10.1097/00004714-199712000-00016

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  7 in total

Review 1.  Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.

Authors:  M R Caligiuri; D V Jeste; J P Lacro
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

Review 2.  Movement disorders of the mouth: a review of the common phenomenologies.

Authors:  C M Ghadery; L V Kalia; B S Connolly
Journal:  J Neurol       Date:  2022-07-29       Impact factor: 6.682

3.  Treatment recommendations for extrapyramidal side effects associated with second-generation antipsychotic use in children and youth.

Authors:  Tamara Pringsheim; Asif Doja; Stacey Belanger; Scott Patten
Journal:  Paediatr Child Health       Date:  2011-11       Impact factor: 2.253

4.  [Not Available].

Authors:  Tamara Pringsheim; Asif Doja; Stacey Belanger; Scott Patten
Journal:  Paediatr Child Health       Date:  2012-10       Impact factor: 2.253

5.  Tardive Dystonia.

Authors:  Frank Skidmore; Stephen G Reich
Journal:  Curr Treat Options Neurol       Date:  2005-05       Impact factor: 3.972

Review 6.  The Symptomatic Treatment of Acquired Dystonia: A Systematic Review.

Authors:  Corina N A M van den Heuvel; Marina A J Tijssen; Bart P C van de Warrenburg; Cathérine C S Delnooz
Journal:  Mov Disord Clin Pract       Date:  2016-08-03

7.  Treatment of severe neuroleptic-induced tardive torticollis.

Authors:  Beata J Havaki-Kontaxaki; Vassilis P Kontaxakis; Maria M Margariti; Konstantinos G Paplos; George N Christodoulou
Journal:  Ann Gen Hosp Psychiatry       Date:  2003-10-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.